Title |
Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease – a prospective observational study
|
---|---|
Published in |
BMC Nephrology, July 2013
|
DOI | 10.1186/1471-2369-14-142 |
Pubmed ID | |
Authors |
Martina Peiskerová, Marta Kalousová, Vilem Danzig, Blanka Míková, Magdalena Hodková, Eduard Němeček, Amjad Bani-Hani, David Ambrož, Hana Benáková, Ales Linhart, Tomas Zima, Vladimir Tesař |
Abstract |
Placental growth factor [PlGF) is a cardiovascular (CV) risk marker, which is related to left ventricle hypertrophy (LVH) in animal models. Currently there are no data available regarding the possible relationship of PlGF and the development of LVH or diastolic dysfunction in patients with chronic kidney disease (CKD) and the relationship of PlGF to other CV risk factors in CKD patients. The aim of our study was to determine the possible association of PlGF and several other CV risk markers to echocardiographic parameters in CKD population. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 29 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 5 | 17% |
Student > Master | 4 | 14% |
Student > Bachelor | 3 | 10% |
Lecturer | 2 | 7% |
Student > Ph. D. Student | 2 | 7% |
Other | 8 | 28% |
Unknown | 5 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 15 | 52% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 7% |
Business, Management and Accounting | 1 | 3% |
Veterinary Science and Veterinary Medicine | 1 | 3% |
Psychology | 1 | 3% |
Other | 1 | 3% |
Unknown | 8 | 28% |